$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923031540 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$4.702M	$3.366M
YoY Change	93.64%	51.67%
Cost Of Revenue	$2.029M	$1.491M
YoY Change	91.5%	56.79%
Gross Profit	$2.673M	$1.875M
YoY Change	95.29%	47.83%
Gross Profit Margin	56.84%	55.71%
Selling, General & Admin	$2.504M	$2.827M
YoY Change	0.34%	12.28%
% of Gross Profit	93.71%	150.76%
Research & Development	$2.268M	$2.775M
YoY Change	3.18%	32.33%
% of Gross Profit	84.86%	148.01%
Depreciation & Amortization	$348.2K	$423.0K
YoY Change	-23.8%	13.41%
% of Gross Profit	13.03%	22.56%
Operating Expenses	$4.773M	$5.602M
YoY Change	1.67%	21.4%
Operating Profit	-$2.100M	-$3.727M
YoY Change	-36.86%	11.38%
Interest Expense	-$1.537M	-$731.6K
YoY Change	246.69%	141.17%
% of Operating Profit
Other Income/Expense, Net	-$26.26K	-$753.7K
YoY Change	-247.94%	134.52%
Pretax Income	-$3.663M	-$4.481M
YoY Change	-2.35%	22.17%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$3.663M	-$4.500M
YoY Change	-2.35%	21.62%
Net Earnings / Revenue	-77.9%	-133.69%
Basic Earnings Per Share		-$0.62
Diluted Earnings Per Share	-$0.46	-$0.62
COMMON SHARES
Basic Shares Outstanding	7.890M	6.827M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$781.3K	$876.9K
YoY Change	-82.0%	-57.33%
Cash & Equivalents	$781.3K	$876.9K
Short-Term Investments
Other Short-Term Assets	$458.3K	$240.5K
YoY Change	-28.77%	-36.18%
Inventory	$1.534M	$1.904M
Prepaid Expenses	$458.3K	$240.5K
Receivables	$2.079M	$1.541M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.852M	$4.563M
YoY Change	-37.64%	-10.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.659M	$4.139M
YoY Change	-28.23%	-49.18%
Goodwill
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$224.7K
YoY Change	-100.0%
Total Long-Term Assets	$14.16M	$15.12M
YoY Change	59.41%	80.86%
TOTAL ASSETS
Total Short-Term Assets	$4.852M	$4.563M
Total Long-Term Assets	$14.16M	$15.12M
Total Assets	$19.01M	$19.69M
YoY Change	14.09%	46.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.100M	$2.582M
YoY Change	-52.99%	0.78%
Accrued Expenses	$746.0K	$745.1K
YoY Change	433.64%	512.88%
Deferred Revenue
YoY Change
Short-Term Debt	$1.629M	$1.158M
YoY Change	69.69%
Long-Term Debt Due	$12.71M	$8.820M
YoY Change	1078.14%	699.52%
Total Short-Term Liabilities	$17.34M	$13.37M
YoY Change	160.96%	233.83%
LONG-TERM LIABILITIES
Long-Term Debt	$2.293M	$3.502M
YoY Change	-69.81%	-55.52%
Other Long-Term Liabilities	$6.177M	$6.342M
YoY Change	8513.18%	6341.02%
Total Long-Term Liabilities	$8.469M	$9.844M
YoY Change	10.49%	23.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.34M	$13.37M
Total Long-Term Liabilities	$8.469M	$9.844M
Total Liabilities	$25.81M	$23.21M
YoY Change	80.35%	93.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.00M	-$39.40M
YoY Change	58.67%	69.1%
Common Stock	$789.00	$789.00
YoY Change	-78.83%	-76.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.796M	-$3.524M
YoY Change
Total Liabilities & Shareholders Equity	$19.01M	$19.69M
YoY Change	14.09%	46.26%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$3.663M	-$4.500M
YoY Change	-2.35%	21.62%
Depreciation, Depletion And Amortization	$348.2K	$423.0K
YoY Change	-23.8%	13.41%
Cash From Operating Activities	-$2.276M	-$2.248M
YoY Change	-30.35%	26.1%
INVESTING ACTIVITIES
Capital Expenditures	-$36.76K	$45.33K
YoY Change	-96.47%	-96.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$36.76K	-$45.33K
YoY Change	-96.47%	-96.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.144M	2.933M
YoY Change	-52.5%	-14.34%
NET CHANGE
Cash From Operating Activities	-2.276M	-2.248M
Cash From Investing Activities	36.76K	-45.33K
Cash From Financing Activities	2.144M	2.933M
Net Change In Cash	-95.58K	638.9K
YoY Change	-104.18%	82.46%
FREE CASH FLOW
Cash From Operating Activities	-$2.276M	-$2.248M
Capital Expenditures	-$36.76K	$45.33K
Free Cash Flow	-$2.239M	-$2.294M
YoY Change	0.51%	-25.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7889896
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7889896
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6211206
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6211206
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q3	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	377092	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1443532	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1222999	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1060299	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1076140	usd
CY2023Q3	guer	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	5986355	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11166417	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4079444	usd
CY2023Q3	guer	Operating Lease Liability Remainder Of Fiscal Year OperatingLeaseLiabilityRemainderOfFiscalYear	185583	usd
CY2023Q3	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	731749	usd
CY2023Q3	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	587879	usd
CY2023Q3	guer	Operating Lease Liability Year Three OperatingLeaseLiabilityYearThree	479477	usd
CY2023Q3	guer	Operating Lease Liability Year Four OperatingLeaseLiabilityYearFour	551585	usd
CY2023Q3	guer	Operating Lease Liability After Year Four OperatingLeaseLiabilityAfterYearFour	4550700	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7086973	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	306035	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1224139	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	903372	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	810528	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	137155	usd
CY2023Q3	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	22944	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3404173	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	370903	usd
CY2023Q3	guer	Finance Lease Liability Remainder Of Fiscal Year FinanceLeaseLiabilityRemainderOfFiscalYear	252810	usd
CY2023Q3	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	1057359	usd
CY2023Q3	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	803224	usd
CY2023Q3	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	767226	usd
CY2023Q3	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	131296	usd
CY2023Q3	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	21355	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	3033270	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56238
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Pisgah Church Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27455
	dei	City Area Code CityAreaCode	336
	dei	Local Phone Number LocalPhoneNumber	510-7840
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7889896
CY2023Q3	us-gaap	Cash Cash	876911	usd
CY2022Q4	us-gaap	Cash Cash	4340407	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1541483	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1124971	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1903929	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	240537	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	643401	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	4562860	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7781704	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3574746	usd
CY2023Q3	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	224656	usd
CY2022Q4	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10760967	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4138530	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5098097	usd
CY2023Q3	us-gaap	Assets Assets	19687013	usd
CY2022Q4	us-gaap	Assets Assets	16664216	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2581714	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4426477	usd
CY2023Q3	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	1157815	usd
CY2022Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	959803	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	63200	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	745144	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1041010	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	7778600	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13367483	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6604580	usd
CY2023Q3	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	733511	usd
CY2022Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	44279	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6341829	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1992260	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4604132	usd
CY2023Q3	us-gaap	Liabilities Liabilities	23211460	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14309323	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	789	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	621	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35851380	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29427440	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39376616	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27073168	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3524447	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19687013	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16664216	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3365911	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2219304	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10376133	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9172565	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1490779	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	950841	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4444005	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3775881	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1875132	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1268463	usd
	us-gaap	Gross Profit GrossProfit	5932128	usd
	us-gaap	Gross Profit GrossProfit	5396684	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2775430	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2097276	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8014588	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5916216	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1445790	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1192286	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4437683	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3447564	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1381119	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1325383	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4304624	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3828763	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5602339	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4614945	usd
	us-gaap	Operating Expenses OperatingExpenses	16756895	usd
	us-gaap	Operating Expenses OperatingExpenses	13192543	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3727207	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3346482	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10824767	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7795859	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-731618	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-303368	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1462487	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-431442	usd
CY2023Q3	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	47400	usd
CY2022Q3	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	-0	usd
	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	47400	usd
	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	-0	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25277	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18028	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31206	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48279	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-753741	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-321396	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1478681	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-479721	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4480948	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3667878	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12303448	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8275580	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.8
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.49
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7211095
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5552736
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6841253
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538781
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4001418	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3658675	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	268640	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2380790	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3821082	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	96757	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	330177	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1013358	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4480948	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1685226	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	284633	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3524447	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	32856	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2741612	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	181302	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4527313	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3667878	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	470384	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	153164	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1482983	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12303448	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8275580	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1244394	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	900637	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	883450	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	367322	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	200799	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	13898	usd
	us-gaap	Accretion Expense AccretionExpense	318585	usd
	us-gaap	Accretion Expense AccretionExpense	16910	usd
	guer	Impairment Property Plant And Equipment And Operating Lease ImpairmentPropertyPlantAndEquipmentAndOperatingLease	105055	usd
	guer	Impairment Property Plant And Equipment And Operating Lease ImpairmentPropertyPlantAndEquipmentAndOperatingLease		usd
	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	47400	usd
	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	416512	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-753147	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	231004	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	313064	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-932917	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-810526	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1764028	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-254219	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-196597	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11178989	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5980423	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	138470	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1590027	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-138470	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1590027	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	10864539	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7213761	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5440658	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	470384	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	7072726	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2640686	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	812315	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	737338	usd
	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	421962	usd
	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	-0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	144231	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7853963	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4311353	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3463496	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3259097	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	876911	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2054888	usd
	guer	Modification On Finance Lease ModificationOnFinanceLease	358487	usd
	guer	Modification On Finance Lease ModificationOnFinanceLease	0	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	512389	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	4811873	usd
	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	173360	usd
	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7289971	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	guer	Financing Of Mask Set FinancingOfMaskSet	256693	usd
	guer	Financing Of Mask Set FinancingOfMaskSet	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1615489	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><em style="font: inherit;">1.</em> ORGANIZATION AND NATURE OF BUSINESS</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of <em style="font: inherit;">1934,</em> as amended (“the Exchange Act”), with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger. On <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation was merged with and into the Company.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">All references in these unaudited interim condensed consolidated financial statements and related Quarterly Report to “Guerrilla RF” refer to: (i) for periods prior to <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation; and (ii) for subsequent periods, Guerrilla RF, Inc. </span><span style="background-color:#ffffff;">Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed to be the accounting acquirer in the Merger and, consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Liquidity and Going Concern</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In accordance with Financial Accounting Standards (“FASB”) Accounting Standards Update (“ASU”) <i><em style="font: inherit;">No.</em></i> <i><em style="font: inherit;">2014</em></i>-<i><em style="font: inherit;">15,</em> Disclosure of Uncertainties about an Entity</i>’<i>s Ability to Continue as a Going Concern (Subtopic</i> <i><em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the unaudited interim condensed consolidated financial statements are issued. The accompanying unaudited interim condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities through a combination of commercial loans and the proceeds of debt and equity issuances. <span style="background-color:#ffffff">The unaudited interim condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>GUERRILLA RF, INC. AND SUBSIDIARIES</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</i></b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">(Unaudited)</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: justify;">The Company has incurred substantial negative cash flows from operations in nearly every fiscal period since inception, including a net loss of $4.5 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023.</em> As of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023,</em> the Company had an accumulated deficit of $39.4 million, a significant portion of which is attributable to the Company’s ongoing investment in research and development, investment in its facilities to support plans for business expansion and growth, and expenses associated with its sales and marketing efforts in support of new product offerings. Management has recently introduced a series of cost-cutting measures, including voluntary salary reductions by the executive management team, which are expected to ultimately reduce annualized expenses between $3.0 million and $5.0 million over the next several quarters. As a result, the Company expects to break even on an operating basis, i.e., excluding interest expense, and other non-operating and non-recurring expenses, by mid-<em style="font: inherit;">2024</em> when revenues are projected to grow to a level that are in excess of operating expenses. In the meantime and until the Company consistently realizes positive net income, it will continue to require additional funding.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company had a cash balance of $877 thousand at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023.</em> </span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">In <em style="font: inherit;"> June 2022, </em>the Company established a loan facility with Spectrum Commercial Services Company, L.L.C. ("Spectrum") providing for advances of up to $3.0 million (the "Spectrum Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> September 30, 2023, </em>the outstanding balance under the Spectrum Loan Facility was $1.0 million. </span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> August </em><em style="font: inherit;">2022,</em> the Company established a loan facility with Salem Investment Partners V, Limited Partnership ("Salem") providing for aggregate advances of up to $8.0 million (the "Salem Loan Facility", further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> June 30, 2023, </em>Salem had advanced $6.5 million to the Company. On <em style="font: inherit;"> August 14, 2023, </em>Salem advanced the remaining <em style="font: inherit;">$1.5</em> million to the Company. On <em style="font: inherit;"> September </em><em style="font: inherit;">5,</em> <em style="font: inherit;">2023,</em> the Company entered into an amended and restated loan agreement with Salem (the “A&R Loan Agreement”) in order to provide for additional advances of up to $4.0 million (the “Additional Advances”). The Additional Advances have an interest rate of 14.0% per annum, with payment of interest deferred until the <em style="font: inherit;"> April 30, 2024 </em>maturity date, i.e., "paid-in-kind". On <em style="font: inherit;"> September 6, 2023, </em>the Company drew down $1.75 million of the Additional Advances. Accordingly, as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023,</em> the undiscounted outstanding balance under the Salem Loan Facility was $9.75 million. As discussed in Note <em style="font: inherit;">13,</em> subsequent to <em style="font: inherit;"> September 30, 2023, </em>the Company drew down an additional $1.25 million under the Salem Loan Facility, leaving up to $1.0 million available for future draws. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">In <em style="font: inherit;"> July 2023, </em>the Company issued unsecured convertible promissory notes in the aggregate amount of $790,000.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As noted above, the Company will continue to require additional funding until it consistently realizes positive net income. Potentially, the Company could draw down additional funds under the Spectrum Loan Facility; however, its ability to do so is dependent upon the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility, which value fluctuates from time to time and is ultimately outside of the Company’s control. The Company <em style="font: inherit;"> may </em>also draw down the remaining $1.0 million in Additional Advances under the Salem Loan Facility; however, Salem has discretion to withhold any further Additional Advances and there is <em style="font: inherit;">no</em> assurance that it will agree to provide access to the remaining $1.0 million under the Salem Loan Facility.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Spectrum Loan Facility expires in <em style="font: inherit;"> June 2024, </em>and automatically renews annually thereafter unless either party elects to terminate the facility upon <em style="font: inherit;">not</em> less than <em style="font: inherit;">60</em> days prior notice. The Company anticipates that the Spectrum Loan Facility will renew and be extended through <em style="font: inherit;"> June 2025, </em>at a minimum. The Salem Loan Facility matures on <em style="font: inherit;"> April 30, 2024. </em>The Company is currently exploring options for the renewal and extension of the Salem Loan Facility, as well as alternative financing and other strategic opportunities to support the Company's business.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company believes that its existing cash and cash equivalents, together with additional financing under the Salem Loan Facility, will provide sufficient resources to support operations through mid-<em style="font: inherit;"> February 2024, </em>with additional funding being required in early <em style="font: inherit;">2024</em> to finance the Company until it consistently achieves positive net income. In the event the Company is unable to draw down the remaining $1.0 million under the Salem Loan Facility or secure alternative funding sources, it <em style="font: inherit;"> may </em>be unable to fund ongoing operations and pay its obligations as they become due before the end of fiscal <em style="font: inherit;">2023.</em> Additionally, if the Company is unable to secure additional funding in early <em style="font: inherit;">2024,</em> it <em style="font: inherit;"> may </em>be unable to fund ongoing operations and pay its obligations as they become due before the end of <em style="font: inherit;"> February 2024. </em>The Company must also make arrangements to renew or replace the Spectrum and Salem Loan Facilities before they mature. There is <em style="font: inherit;">no</em> assurance that appropriate additional funding (or in the case of the Spectrum and Salem Loan Facilities, the renewal of existing loan facilities) will be available on terms, which are acceptable to us, or at all. This requirement for additional funding and the renewal of existing loan facilities raises substantial doubt about our ability to continue as a going concern.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>GUERRILLA RF, INC. AND SUBSIDIARIES</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"><b><i>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</i></b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">(Unaudited)</p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><span style="background-color:#ffffff;">Risks and Uncertainties</span></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions including the current macro-economic conditions impacting the banking and financial markets.</p>
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4500000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39400000	usd
CY2023Q3	us-gaap	Cash Cash	877000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of our unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition, the valuation of share-based compensation, and the valuation of equity financing, including the underlying fair value of the common stock. Accordingly, actual results could differ from those estimates.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Reclassifications</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain prior period income statement and balance sheets amounts have been reclassified to conform to the Company's fiscal <em style="font: inherit;">2023</em> presentation. These reclassifications have <em style="font: inherit;">no</em> impact on the Company's previously reported net loss.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023,</em> and <em style="font: inherit;"> December 31, 2022 </em>that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from revenue earned from customers located inside and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s aggregate annual revenue. The Company had<span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"><span style="-sec-ix-hidden:c104953551"><span style="-sec-ix-hidden:c104953552">one</span></span> </span></span><span style="background-color:#ffffff;">major distributor customer, </span>Richardson RFPD, Inc. ("RFPD"). <span style="background-color:#ffffff">RFPD, a large product distributor serving numerous end-user customers,</span> <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">accounted</span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> for </span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">81% of product shipment revenue</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022.</em> Accounts receivable from RFPD represented 78</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">% and 76% of accounts receivable</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023</em> and <em style="font: inherit;"> December 31, </em><em style="font: inherit;">2</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"><em style="font: inherit;">022,</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> r</span></span><span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">espectively.</span></p>
CY2022Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q4	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q2	guer	Proceeds From Accounts Receivable Factoring ProceedsFromAccountsReceivableFactoring	3000000	usd
CY2023Q3	guer	Accounts Receivable Secured Debt Facility Receivables Assigned AccountsReceivableSecuredDebtFacilityReceivablesAssigned	1000000	usd
CY2023Q3	guer	Accounts Receivable Secured Debt Facility Amount Due AccountsReceivableSecuredDebtFacilityAmountDue	48500	usd
	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	250000	usd
	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	0	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	6	pure
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7211095
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5552736
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1892631
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	738783
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5098097	usd
	us-gaap	Depreciation Depreciation	1244394	usd
	us-gaap	Depreciation Depreciation	900637	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	343639	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	696409	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	113933	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	44037	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1446357	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932479	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1903929	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8167990	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7999029	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4029460	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2900932	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4138530	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1028308	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8737348	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	226241	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	231884	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	187417	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	35105	usd
CY2023Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10446303	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	94667
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	210000
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	4.2
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	9.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.45	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.45	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0473	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0379	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0473	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0379	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.4
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	395753	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	538812	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	367322000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	601220
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.54
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9333
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.97
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2863
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.41
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	607690
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.6
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3800
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.8
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	123
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.19
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	611367
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M4D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1800
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.18
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	609567
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M28D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	520043
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M29D
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	600000	usd
CY2023Q3	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	400000	usd
	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P2Y3M18D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	883450000	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	63200	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10760967	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	745144	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6341829	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7086973	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4917140	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1041010	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1992260	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	3033270	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1210436	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	99772	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	944413	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	615102	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	198778	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	163107	usd
	guer	Finance Lease Cost FinanceLeaseCost	1143191	usd
	guer	Finance Lease Cost FinanceLeaseCost	778209	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y9M3D
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M9D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.11	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0729	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	1357074	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	197141	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	812315	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	191509	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	711783	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	635120	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree	580822	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour	524555	usd
CY2023Q3	guer	Lessee Operating Lease Liability Undiscounted Excess Amount After Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFour	1435655	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year FinanceLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	53225	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	166780	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	100148	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	43302	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	5859	usd
CY2023Q3	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	1589	usd
CY2023Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1500000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2023Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	87205	usd
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	93728	usd

Files In Submission

Name	View Source	Status
0001437749-23-031540-index-headers.html	Edgar Link	pending
0001437749-23-031540-index.html	Edgar Link	pending
0001437749-23-031540.txt	Edgar Link	pending
0001437749-23-031540-xbrl.zip	Edgar Link	pending
ex_562969.htm	Edgar Link	pending
ex_562970.htm	Edgar Link	pending
ex_562971.htm	Edgar Link	pending
ex_562972.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20230930.xsd	Edgar Link	pending
guer20230930_10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
guer-20230930_cal.xml	Edgar Link	unprocessable
guer-20230930_def.xml	Edgar Link	unprocessable
guer-20230930_lab.xml	Edgar Link	unprocessable
guer-20230930_pre.xml	Edgar Link	unprocessable
guer20230930_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2023 Q4 Form 10-Q Financial Statement

#000143774923031540 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2023 Q4 Form 10-Q Financial Statement

#000143774923031540 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer